Literature DB >> 7977808

ACE in three tunicae of rat aorta: expression in smooth muscle and effect of renovascular hypertension.

J F Arnal1, T Battle, C Rasetti, M Challah, O Costerousse, E Vicaut, J B Michel, F Alhenc-Gelas.   

Abstract

Angiotensin I-converting enzyme (ACE) is known to be present at the surface of endothelial cells and also in the adventitia in large vessels. The presence of ACE in the vascular smooth muscle remains controversial. We microdissected segments of adventitia and media with or without endothelium from a region devoid of collateral arteries. The membrane-bound ACE activity in the media averaged 41% (pmol [glycine-1-14C]hippuryl-L-histidyl-L-leucine hydrolyzed.g tissue-1.min-1) of the values found in the whole aorta, whereas the adventitia contained only 6%. Immunoreactive ACE in media was characterized by Western blotting. ACE mRNAs were detected and characterized after polymerase chain amplification in isolated media. Angiotensin I and angiotensin II were equally able to contract medial rings, and the response to angiotensin I was blocked by enalaprilat. In aortas of two-kidney, one-clip hypertensive rats, there was an increase in ACE mRNA estimated by ribonuclease protection assay (P = 0.02) and in ACE activity at 15 days and 1 and 3 mo after clipping. This corresponded to a 1.5- to 2-fold increase in the ACE activity of both the media and the adventitia compared with sham-operated rats (P < or = 0.02). Thus ACE gene expression occurs in smooth muscle of rat aorta, which contains roughly the same amount of enzyme as the endothelium and readily converts angiotensin I to angiotensin II. ACE in the medial layer and the adventitia is upregulated in renovascular hypertension.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7977808     DOI: 10.1152/ajpheart.1994.267.5.H1777

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

Review 1.  Angiotensin-converting enzymes and drug discovery in cardiovascular diseases.

Authors:  Lijun Shi; Caiping Mao; Zhice Xu; Lubo Zhang
Journal:  Drug Discov Today       Date:  2010-02-17       Impact factor: 7.851

2.  Angiotensin-Converting Enzyme in Smooth Muscle Cells Promotes Atherosclerosis-Brief Report.

Authors:  Xiaofeng Chen; Deborah A Howatt; Anju Balakrishnan; Jessica J Moorleghen; Congqing Wu; Lisa A Cassis; Alan Daugherty; Hong Lu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-04-07       Impact factor: 8.311

3.  Effects of angiotensin I and angiotensin II in blood vessels: greater influence of converting enzyme activity in the rabbit basilar artery.

Authors:  A Zerrouk; M Auguet; S Delaflotte; P E Chabrier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

4.  A new experimental approach in endothelium-dependent pharmacological investigations on isolated porcine coronary arteries mounted for impedance planimetry.

Authors:  L B Tankó; E O Mikkelsen; U Simonsen
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

Review 5.  Cardiovascular effects of losartan and its relevant clinical application.

Authors:  Feichao Xu; Caiping Mao; Yali Hu; Can Rui; Zhice Xu; Lubo Zhang
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

6.  Angiotensin-converting enzyme gene polymorphism in Behçet's disease.

Authors:  M Akif Oztürk; Meral Calgüneri; Sedat Kiraz; Ihsan Ertenli; A Mesut Onat; Kemal Ureten; Zeynep Ozbalkan; Ibrahim C Haznedaroğlu
Journal:  Clin Rheumatol       Date:  2004-02-24       Impact factor: 2.980

7.  Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension.

Authors:  N W Morrell; E N Atochina; K G Morris; S M Danilov; K R Stenmark
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.